SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 95 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $95,000 | 0.0% | 99,019 | +22.9% | 0.00% | – |
| Q1 2022 | $95,000 | -58.1% | 80,577 | +15.4% | 0.00% | – |
| Q4 2021 | $227,000 | -77.9% | 69,839 | -69.6% | 0.00% | – |
| Q3 2021 | $1,025,000 | -53.4% | 229,425 | -43.1% | 0.00% | – |
| Q2 2021 | $2,198,000 | -21.5% | 403,339 | +7.8% | 0.00% | – |
| Q1 2021 | $2,799,000 | +240.5% | 374,131 | +393.7% | 0.00% | – |
| Q4 2020 | $822,000 | +1108.8% | 75,788 | +886.1% | 0.00% | – |
| Q3 2020 | $68,000 | -73.0% | 7,686 | -67.5% | 0.00% | – |
| Q2 2020 | $252,000 | +663.6% | 23,652 | +329.6% | 0.00% | – |
| Q1 2020 | $33,000 | -90.7% | 5,506 | -89.3% | 0.00% | – |
| Q4 2019 | $355,000 | +238.1% | 51,374 | +409.9% | 0.00% | – |
| Q3 2019 | $105,000 | +775.0% | 10,076 | +703.5% | 0.00% | – |
| Q2 2019 | $12,000 | -74.5% | 1,254 | -75.2% | 0.00% | – |
| Q1 2019 | $47,000 | -78.4% | 5,053 | -87.1% | 0.00% | – |
| Q4 2018 | $218,000 | -60.6% | 39,224 | -15.7% | 0.00% | – |
| Q3 2018 | $554,000 | -0.4% | 46,555 | -14.6% | 0.00% | – |
| Q2 2018 | $556,000 | +13.0% | 54,504 | +43.7% | 0.00% | – |
| Q1 2018 | $492,000 | +85.7% | 37,919 | +39.7% | 0.00% | – |
| Q4 2017 | $265,000 | -32.4% | 27,144 | +2.1% | 0.00% | – |
| Q3 2017 | $392,000 | +66.8% | 26,577 | +82.1% | 0.00% | – |
| Q2 2017 | $235,000 | -32.1% | 14,597 | -32.6% | 0.00% | – |
| Q1 2017 | $346,000 | -54.1% | 21,664 | -65.1% | 0.00% | – |
| Q4 2016 | $754,000 | +60.8% | 62,088 | +83.6% | 0.00% | – |
| Q3 2016 | $469,000 | – | 33,814 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |